Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support
$5,300
BUY NOW GET FREE SAMPLE

FAQs

Contrast Media Market size was valued at USD 6.55 Billion in 2023 and is poised to grow from USD 7.03 Billion in 2024 to USD 12.46 Billion by 2032, growing at a CAGR of 7.4% during the forecast period (2025-2032).

To increase their market share in the market, major firms are implementing tactics including collaborations, acquisitions, and mergers. They are also introducing new goods. 'GE Healthcare (US) ', 'Bracco Imaging S.p.A. (Italy) ', 'Bayer AG (Germany) ', 'Guerbet (France) ', 'Lantheus Medical Imaging (US) ', 'Unijules Life Sciences Ltd. (India) ', 'J.B. Chemicals & Pharmaceuticals Limited (India) ', 'Taejoon Pharm Co., Ltd. (South Korea) ', 'Jodas Expoim (India) ', 'Imax Diagnostic Imaging Limited (Ireland) ', 'Yangtze River Pharmaceutical Group (China) ', 'Livealth Biopharma (India) ', 'Beijing Beilu Pharmaceutical Co., Ltd. (China) ', 'Unispire Biopharma Private Limited (India) ', 'Arco Lifesciences (I) Pvt. Ltd. (India) ', 'Stanex Drugs & Chemicals Pvt. Ltd. (India) ', 'Rege Imaging & Cine Films Private Limited (India) ', 'K Diam Exim (India) ', 'Onko Ilaç San. ve Tic. A.S. (Turkey) ', 'Fresenius Kabi (Germany) ', 'Biem Ilaç San. ve Tic. A.S. (Turkey) ', 'Advacare Pharma (US)'

The demand for diagnostic imaging treatments and, consequently, contrast media has significantly increased as a result of the growing incidence of chronic illnesses throughout the world. In order to provide new goods to the market and get the contrast media authorized for new indications, contrast media makers have been doing substantial R&D as a consequence of the rising demand for imaging operations. For instance, the 20-vial pack design of the ultrasound contrast agent Lumason was approved by the US FDA in 2021 for use by Bracco.

A kind of intravenous radiocontrast (radiographic dye) called iodinated contrast medium makes vascular systems and organs more visible during radiographic operations. The iodinated contrast has aided in the identification of disorders like cancer by improving visibility. The 2, 4, and 6 tri-iodinated benzene rings were chemically modified to create the iodinated contrast media that are currently in use.

North America held the largest share of the global contrast media market in 2021. It was roughly 44.44%. This is expected to change as a result of numerous strategic initiatives done by important manufacturers to target certain patient subgroups in this area. GE Healthcare, Guerbet, Lantheus, and Bracco Diagnostics are some of the major market participants.

Feedback From Our Clients

Global Contrast Media Market

Report ID: SQMIG35B2070

$5,300
BUY NOW GET FREE SAMPLE

This site uses cookies. See Our Privacy And Policy For More info.